Literature DB >> 15085484

The pathology of cholestasis.

Melissa K Li1, James M Crawford.   

Abstract

Hepatic formation of bile is critical to survival and is one of the most easily disrupted liver functions. Liver biopsy is performed to obtain a definitive diagnosis of cause, to exclude potential etiologies, or simply to assist in development of a differential diagnosis. Parenchymal changes of cholestasis (feathery degeneration of hepatocytes, dilated bile canaliculi with retained bile, Kupffer cell phagocytosis of bile that has leaked into the sinusoidal space) are nonspecific and may be seen with both nonobstructive and obstructive cholestasis. The portal tract changes of obstruction are characteristic: bile ductular proliferation, inspissated bile in bile ducts, portal tract edema, neutrophilic inflammation, and cholate stasis of periportal hepatocytes. Uncorrected obstruction incites robust fibrogenesis by portal tract myofibroblasts, engendering a characteristic jigsaw pattern of fibrous septa. Diseases with specific histological features include primary biliary cirrhosis, primary sclerosing cholangitis, biliary atresia, and graft-versus-host disease. However, the pathologist is cautioned not to overinterpret the cholestatic liver biopsy and to apply rigorous criteria for specific causal diagnoses. Most of the histological features of cholestasis are nonspecific. Hence, both practicing physician and pathologist should have sound knowledge of the pathology of cholestasis.

Entities:  

Mesh:

Year:  2004        PMID: 15085484     DOI: 10.1055/s-2004-823099

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  41 in total

1.  Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.

Authors:  Nikita Joshi; Anna K Kopec; Holly Cline-Fedewa; James P Luyendyk
Journal:  Toxicology       Date:  2016-12-31       Impact factor: 4.221

Review 2.  Nuclear receptors and inflammatory diseases.

Authors:  Kun Wang; Yu-Jui Yvonne Wan
Journal:  Exp Biol Med (Maywood)       Date:  2008-03-28

3.  [Secondary sclerosing cholangitis after multiple trauma and long-term intensive care treatment: case report of a characteristic course].

Authors:  M Seemann; G Kirchner; S Bele; B Sinner; B Graf; M Kieninger
Journal:  Anaesthesist       Date:  2013-01-24       Impact factor: 1.041

4.  IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis.

Authors:  Kate M O'Brien; Katryn M Allen; Cheryl E Rockwell; Keara Towery; James P Luyendyk; Bryan L Copple
Journal:  Am J Pathol       Date:  2013-09-05       Impact factor: 4.307

5.  Dose-dependent effects of alpha-naphthylisothiocyanate disconnect biliary fibrosis from hepatocellular necrosis.

Authors:  Nikita Joshi; Jessica L Ray; Anna K Kopec; James P Luyendyk
Journal:  J Biochem Mol Toxicol       Date:  2016-09-08       Impact factor: 3.642

Review 6.  Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology.

Authors:  Tirthadipa Pradhan-Sundd; Satdarshan Pal Monga
Journal:  Gene Expr       Date:  2019-01-15

7.  Monitoring impacts of air pollution: PIXE analysis and histopathological modalities in evaluating relative risks of elemental contamination.

Authors:  Sohail Ejaz; Gerry Amor Camer; Khaleeq Anwar; Muhammad Ashraf
Journal:  Ecotoxicology       Date:  2014-01-28       Impact factor: 2.823

8.  The interstitial lymphatic peritoneal mesothelium axis in portal hypertensive ascites: when in danger, go back to the sea.

Authors:  M A Aller; I Prieto; S Argudo; F de Vicente; L Santamaría; M P de Miguel; J L Arias; J Arias
Journal:  Int J Inflam       Date:  2010-10-05

9.  Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling.

Authors:  Katryn Allen; Nam Deuk Kim; Jeon-Ok Moon; Bryan L Copple
Journal:  Toxicol Appl Pharmacol       Date:  2009-11-17       Impact factor: 4.219

10.  Experimental obstructive cholestasis: the wound-like inflammatory liver response.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jose García-Domínguez; Jose-Ignacio Arias; Manuel Durán; Jaime Arias
Journal:  Fibrogenesis Tissue Repair       Date:  2008-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.